Previous close | 7.96 |
Open | 7.95 |
Bid | 7.92 x 200 |
Ask | 7.97 x 200 |
Day's range | 7.76 - 8.20 |
52-week range | 7.72 - 27.48 |
Volume | |
Avg. volume | 1,080,646 |
Market cap | 1.074B |
Beta (5Y monthly) | 0.41 |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
Vir Biotechnology Inc (NASDAQ:VIR), a company focused on the research and development of treatments for serious infectious diseases, has reported an insider sell according to a recent SEC filing.
Q4 2023 Vir Biotechnology Inc Earnings Call
Vir Biotechnology, Inc. (NASDAQ:VIR) Q4 2023 Earnings Call Transcript February 22, 2024 Vir Biotechnology, Inc. beats earnings expectations. Reported EPS is $-0.86, expectations were $-1.14. Vir Biotechnology, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Hello. Welcome to Vir […]